Financial Connections Group’s Harvard Bioscience HBIO Stock Holding History

Financial Connections Group’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	30	–	–	﹤0.01%	247
2025 Q4	$0	Hold	30	–	–	﹤0.01%	232
2025 Q3	$0	Hold	30	–	–	﹤0.01%	248
2025 Q2	$0	Hold	30	–	–	﹤0.01%	248
2025 Q1	$0	Hold	30	–	–	﹤0.01%	221
2024 Q4	$0	Hold	30	–	–	﹤0.01%	231
2024 Q3	$0	Hold	30	–	–	﹤0.01%	262
2024 Q2	$0	Buy	+30	New	+$1.05K	﹤0.01%	335
2024 Q1	–	Sell	-30	Closed	-$1K	–	200
2023 Q4	$1K	Buy	+30	New	+$1.35K	﹤0.01%	209
2023 Q3	–	Sell	-30	Closed	-$1K	–	161
2023 Q2	$1K	Hold	30	–	–	﹤0.01%	227
2023 Q1	$1K	Hold	30	–	–	﹤0.01%	234
2022 Q4	$0	Hold	30	–	–	﹤0.01%	243
2022 Q3	$0	Hold	30	–	–	﹤0.01%	257
2022 Q2	$1K	Hold	30	–	–	﹤0.01%	267
2022 Q1	$1K	Hold	30	–	–	﹤0.01%	270
2021 Q4	$2K	Buy	+30	New	+$2.13K	﹤0.01%	273

Other funds holding HBIO

WCM

Weber Capital Management San Francisco, California $100M AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return

MIM

Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Financial Connections Group's HBIO Position: Q1 2026 in Review

Financial Connections Group held its Harvard Bioscience (HBIO) position steady in Q1 2026 at 30 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #247.

Financial Connections Group first reported a position in HBIO in Q4 2021 and has held it in 16 quarters since. The position peaked at $2K in Q4 2021. 36 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.

Financial Connections Group held 30 shares of Harvard Bioscience worth $0 as of Q1 2026.
Financial Connections Group left its Harvard Bioscience share count unchanged in Q1 2026.
Harvard Bioscience made up ﹤0.01% of Financial Connections Group's portfolio in Q1 2026, its #247 holding.
Financial Connections Group first reported a position in Harvard Bioscience in Q4 2021 and has held it in 16 quarters since.
Financial Connections Group's Harvard Bioscience position peaked at $2K in Q4 2021.
36 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.

Based on Financial Connections Group's 13F filing for Q1 2026, filed 1 May 2026.